NL-OMON47108已完成不适用
TOPical Imiquimod treatment of high-grade Cervical intraepithelial neoplasia, a multicenter, open-label, non-randomized, controlled study (TOPIC-3 study) - Imiquimod treatment of CIN lesions
Medisch Universitair Ziekenhuis Maastricht0 个研究点目标入组 123 人开始时间: 待定最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 123
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 64（—）
入选标准
- •- de novo CIN2 or CIN3 lesion, histologically confirmed by diagnostic biopsy
- •- age of 18 years or older
排除标准
- •- previous histologically confirmed high-grade CIN (CIN 2*3)
- •- PAP 4 cytology as indication for the current baseline colposcopy
- •- concomitant vulvar and/or vaginal intraepithelial neoplasia
- •- previous cervical malignancy
- •- current malignant disease
- •- immunodeficiency (including HIV/AIDS and immunodepressive medication)
- •- pregnancy or lactation
- •- legal incapability
- •- insufficient knowledge of the Dutch language
研究者
相似试验
进行中（未招募）
1 期
Imiquimod treatment of premalignant lesions of the uterine cervix.High grade cervical intraepithelial neoplasia.EUCTR2013-001260-34-NLMaastricht University Medical Center210
进行中（未招募）
1 期
Treatment of high-grade Cervical Intraepithelial Neoplasia with imiquimod or surgery.High-grade Cervical Intraepithelial NeoplasiaEUCTR2016-002096-96-NLMaastricht University Medical Center
Unknown
不适用
Imiquimod Treatment of High-grade CINCervical Intraepithelial NeoplasiaNCT02917746Maastricht University Medical Center120
终止
3 期
Imiquimod Treatment of CIN LesionsCervical Intraepithelial NeoplasiaNCT02329171Maastricht University Medical Center9
已完成
2 期
ITIC (Imiquimod Therapy in Cervical Intraepithelial Neoplasia)-TrialCervical Intraepithelial NeoplasiaNCT00941252Medical University of Vienna60